Stockreport

Revolution Medicines to Participate in Upcoming Investor Conferences

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for [Read more]